Geron (GERN) Common Equity (2010 - 2026)
Geron's (GERN) quarterly Common Equity came in at $229.1 million in Q1 2026, down 14.59% year-on-year from $268.2 million in Q1 2025, and up 1.43% quarter-over-quarter from $225.9 million in Q4 2025.
Geron (GERN) Common Equity (2010 - 2026) Analysis & Trends
Geron has disclosed Common Equity across 17 years of filings, most recently posting $229.1 million for Q1 2026.
- Common Equity for Q1 2026 came in at $229.1 million, down 14.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $229.1 million (down 14.59% YoY), and the FY2025 annual result was $225.9 million, down 19.42% from the prior year.
- Common Equity came in at $229.1 million for Q1 2026 at Geron, up from $225.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $344.9 million in Q1 2024 to a low of $80.0 million in Q4 2022.
- The 5-year median for Common Equity is $259.5 million (2025), against an average of $238.0 million.
- Across the five-year window, Common Equity plunged 51.54% in 2022 and jumped 234.46% in 2023, its largest moves.
- Geron's Common Equity stood at $80.0 million in 2022, then jumped by 209.94% to $247.9 million in 2023, then grew by 13.06% to $280.3 million in 2024, then dropped by 19.42% to $225.9 million in 2025, then climbed by 1.43% to $229.1 million in 2026.
- The last three Common Equity figures came in at $229.1 million (Q1 2026), $225.9 million (Q4 2025), and $248.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 13.21 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 229.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.11 Mn |
| Dec 31, 2025 | 225.87 Mn |
| Sep 30, 2025 | 248.71 Mn |
| Jun 30, 2025 | 259.53 Mn |
| Mar 31, 2025 | 268.24 Mn |
| Dec 31, 2024 | 280.32 Mn |
| Sep 30, 2024 | 292.28 Mn |
| Jun 30, 2024 | 306.70 Mn |
| Mar 31, 2024 | 344.87 Mn |
| Dec 31, 2023 | 247.95 Mn |
| Sep 30, 2023 | 290.61 Mn |
| Jun 30, 2023 | 298.43 Mn |
| Mar 31, 2023 | 326.06 Mn |
| Dec 31, 2022 | 80.00 Mn |
| Sep 30, 2022 | 108.17 Mn |
| Jun 30, 2022 | 142.05 Mn |
| Mar 31, 2022 | 97.49 Mn |
| Dec 31, 2021 | 126.42 Mn |
| Sep 30, 2021 | 151.55 Mn |
| Jun 30, 2021 | 176.21 Mn |